← All Rf Acquisition CORP Ii filings

Rf Acquisition CORP Ii Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
RFAI
Rf Acquisition CORP Ii
425: RF Acquisition Corp II Extends Business Combination Deadline
RF Acquisition Corp II has amended its trust agreement and articles of association to extend the deadline for completing a business combination, with shareholders approving the move.
NASDAQ
RFAI
Rf Acquisition CORP Ii
425: RFAC II Extends Merger Deadline to August 2026 Amid Redemptions
RF Acquisition Corp II shareholders approved an extension to complete a business combination until August 15, 2026, despite significant share redemptions.
NASDAQ
RFAI
Rf Acquisition CORP Ii
425: AI Drug Discovery Pioneer Nanyang Biologics to Go Public
Nanyang Biologics, an AI-driven drug discovery company, will go public via a business combination with SPAC RF Acquisition Corp II in a $1.5 billion transaction.
NASDAQ
RFAI
Rf Acquisition CORP Ii
Form 4: RF Acquisition Corp II: CEO Ng Tse Meng Reports Beneficial Ownership Changes
CEO Ng Tse Meng reports changes in beneficial ownership of RF Acquisition Corp II ordinary shares and rights, including acquisitions through derivative securities.
NASDAQ
RFAI
Rf Acquisition CORP Ii
Form 4: Alfa 24 Ltd Reports Changes in Beneficial Ownership of RF Acquisition Corp II
Alfa 24 Ltd, a 10% owner and director of RF Acquisition Corp II, reports changes in beneficial ownership, including the acquisition and disposal of ordinary shares and rights.